Voyager Pharmaceutical   Report issue

For profit Phase 2 Phase 3
Founded: Raleigh NC United States (2001)
Status: Defunct (2013)

Organization Overview

First Clinical Trial
2003
NCT00063310
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2005

Timeline

NOW
  • Now

Alternative names

Sr. Clinical Scientist, Voyager Pharmaceutical | Voyager Pharmaceutical Corporation

Active Ingredients

Drugs in Phase 3 Trials (1)

galantamine (reminyl) (1 trial)

Drugs in Phase 2 Trials (1)

leuprolide (lupron) (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Alzheimer Disease (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 3
  • # of Trial APIs: 2